Martha Zompoulaki

Dr. Martha Zompoulaki

École Normale Supérieure - PSL, Paris, Île-de-France, France

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GSGabrielle Schanne
Gabrielle Schanne
MZMartha Zompoulaki
Martha Zompoulaki
GGGéraldine Gazzah
Géraldine Gazzah
AVAmandine Vincent
Amandine Vincent
HPHugues Preud'homme
Hugues Preud'homme
CPClotilde Policar
Clotilde Policar
Oxidative stress is known to play a major role in the pathogenesis of inflammatory bowel diseases (IBDs), and, in particular, superoxide dismutase (SODs) defenses were shown to be weakened in patients suffering from IBDs. SOD mimics, also called SOD mimetics, as low‐molecular‐weight complexes reproducing the activity of SOD, constitute promising antioxidant catalytic metallodrugs in the context of IBDs. A Mn(II) complex SOD mimic (Mn1) based on an open‐chain diaminoethane ligand exerting antioxidant and anti‐inflammatory effects on an intestinal epithelial cellular model was shown to experience metal exchanges between the manganese center and metal ions present in the biological environment (such as Zn(II)) to some degrees. As the resulting complexes (mainly Zn(II)) were shown to be inactive, improving the kinetic inertness of Mn(II) complexes based on open‐chain ligands is key to improve their bioactivity in a cellular context. We report here the study of three new Mn(II) complexes resulting from Mn1 functionalization with a cyclohexyl and/or a propyl group meant to limit, respectively, (a) metal exchanges and (b) deprotonation of an amine from the 1,2‐diaminoethane central scaffold. The new manganese‐based SOD mimics display a higher intrinsic SOD activity and also improved kinetic inertness in metal ion exchange processes (with Zn(II), Cu(II), Ni(II), and Co(II)). They were shown to provide anti‐inflammatory and antioxidant effects in cells at lower doses than Mn1 (down to 10 μM). This improvement was due to their higher inertness against metal‐assisted dissociation and not to different cellular overall accumulations. Based on its higher inertness, the SOD mimic containing both the propyl and the cyclohexyl moieties was suitable for intracellular detection and quantification by mass spectrometry, quantification, that was achieved by using a 13C‐labeled Co‐based analog of the SOD mimics as an external heavy standard.

Verified
Journal Article
Open access
PDF file
CPCaroline Prieux-Klotz
Caroline Prieux-Klotz
HCHenri Chédotal
Henri Chédotal
MZMartha Zompoulaki
Martha Zompoulaki
SCSandrine Chouzenoux
Sandrine Chouzenoux
CCCharlotte Chêne
Charlotte Chêne
RCRomain Coriat
Romain Coriat
Reactive oxygen species (ROS) are produced by every aerobic cell during mitochondrial oxidative metabolism as well as in cellular response to xenobiotics, cytokines, and bacterial invasion. Superoxide Dismutases (SOD) are antioxidant proteins that convert superoxide anions (O2•−) to hydrogen peroxide (H2O2) and dioxygen. Using the differential in the level of oxidative stress between normal and cancer cells, SOD mimetics can show an antitumoral effect and prevent oxaliplatin-induced peripheral neuropathy. New Pt(IV) conjugate prodrugs (OxPt-x-Mn1C1A (x = 1, 1-OH, 2)), combining oxaliplatin and a Mn SOD mimic (MnSODm Mn1C1A) with a covalent link, were designed. Their stability in buffer and in the presence of sodium ascorbate was studied. In vitro, their antitumoral activity was assessed by the viability and ROS production of tumor cell lines (CT16, HCT 116, KC) and fibroblasts (primary culture and NIH 3T3). In vivo, a murine model of colorectal cancer was created with subcutaneous injection of CT26 cells in Balb/c mice. Tumor size and volume were measured weekly in four groups: vehicle, oxaliplatin, and oxaliplatin associated with MnSODm Mn1C1A and the bis-conjugate OxPt-2-Mn1C1A. Oxaliplatin-induced peripheral neuropathy (OIPN) was assessed using a Von Frey test reflecting chronic hypoalgesia. Tolerance to treatment was assessed with a clinical score including four items: weight loss, weariness, alopecia, and diarrhea. In vitro, Mn1C1A associated with oxaliplatin and Pt(IV) conjugates treatment induced significantly higher production of H2O2 in all cell lines and showed a significant improvement of the antitumoral efficacy compared to oxaliplatin alone. In vivo, the association of Mn1C1A to oxaliplatin did not decrease its antitumoral activity, while OxPt-2-Mn1C1A had lower antitumoral activity than oxaliplatin alone. Mn1C1A associated with oxaliplatin significantly decreased OIPN and also improved global clinical tolerance of oxaliplatin. A neuroprotective effect was observed, associated with a significantly improved tolerance to oxaliplatin without impairing its antitumoral activity.

4 July 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
MZMartha Zompoulaki
Martha Zompoulaki
GSGabrielle Schanne
Gabrielle Schanne
NDNicolas Delsuc
Nicolas Delsuc
HPHugues Preud'HOmme
Hugues Preud'HOmme
EQElodie Quévrain
Elodie Quévrain
CPClotilde Policar
Clotilde Policar

4 July 2022 in Angewandte Chemie
Verified
Journal Article
Closed access
MZMartha Zompoulaki
Martha Zompoulaki
GSGabrielle Schanne
Gabrielle Schanne
NDNicolas Delsuc
Nicolas Delsuc
HPHugues Preud'Homme
Hugues Preud'Homme
EQElodie Quévrain
Elodie Quévrain
CPClotilde Policar
Clotilde Policar

22 March 2025 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
MZMartha Zompoulaki
Martha Zompoulaki
GCGiovanni Chiappetta
Giovanni Chiappetta
JBJean Bouvet
Jean Bouvet
NJNamita‐Raju John
Namita‐Raju John
GSGabrielle Schanne
Gabrielle Schanne
CPClotilde Policar
Clotilde Policar
Overproduction of reactive oxygen species and antioxidant superoxide dismutases (SOD1, SOD2) dysregulation contribute to chronic inflammation such as generated in inflammatory bowel diseases (IBD). A kinetic redox shotgun proteomic strategy (OcSILAC for Oxidized cysteine Stable Isotope Labelling by Amino acids in Cell culture) was used to explore the lipopolysaccharide (LPS) effects including LPS‐induced oxidation and inflammation cascades on a dedicated intestinal epithelial cell line (HT29‐MD2) together with the potential mitigating role of a Mn‐based SOD‐mimic Mn1 . While LPS induced transient oxidative damages at early times (15 min), cells incubated with Mn1 showed, in this time frame, a significantly reduced cysteine oxidation, highlighting Mn1 antioxidant properties. Over time, cysteine oxidation of LPS‐treated cells was counteracted by an overexpression of antioxidant proteins (SOD1, NQO1) and a late (6 h) preponderant increase in SOD2 level. Mn1 , when co‐incubated with LPS, attenuated the level of most LPS‐modified proteins, that is, proteins involved in the inflammatory response. Our results highlight Mn1 as a potentially effective antioxidant and anti‐inflammatory agent to consider in the treatment of IBD, as well as a useful tool for exploring the interconnection between oxidative stress and inflammation.

22 March 2025 in Angewandte Chemie
Verified
Journal Article
Open access
MZMartha Zompoulaki
Martha Zompoulaki
GCGiovanni Chiappetta
Giovanni Chiappetta
JBJean Bouvet
Jean Bouvet
NJNamita‐Raju John
Namita‐Raju John
GSGabrielle Schanne
Gabrielle Schanne
CPClotilde Policar
Clotilde Policar
Overproduction of reactive oxygen species and antioxidant superoxide dismutases (SOD1, SOD2) dysregulation contribute to chronic inflammation such as generated in inflammatory bowel diseases (IBD). A kinetic redox shotgun proteomic strategy (OcSILAC for Oxidized cysteine Stable Isotope Labelling by Amino acids in Cell culture) was used to explore the lipopolysaccharide (LPS) effects including LPS‐induced oxidation and inflammation cascades on a dedicated intestinal epithelial cell line (HT29‐MD2) together with the potential mitigating role of a Mn‐based SOD‐mimic Mn1 . While LPS induced transient oxidative damages at early times (15 min), cells incubated with Mn1 showed, in this time frame, a significantly reduced cysteine oxidation, highlighting Mn1 antioxidant properties. Over time, cysteine oxidation of LPS‐treated cells was counteracted by an overexpression of antioxidant proteins (SOD1, NQO1) and a late (6 h) preponderant increase in SOD2 level. Mn1 , when co‐incubated with LPS, attenuated the level of most LPS‐modified proteins, that is, proteins involved in the inflammatory response. Our results highlight Mn1 as a potentially effective antioxidant and anti‐inflammatory agent to consider in the treatment of IBD, as well as a useful tool for exploring the interconnection between oxidative stress and inflammation.